Nongwoobio Statistics
Total Valuation
Nongwoobio has a market cap or net worth of KRW 115.10 billion. The enterprise value is 106.92 billion.
Market Cap | 115.10B |
Enterprise Value | 106.92B |
Important Dates
The last earnings date was Wednesday, December 4, 2024.
Earnings Date | Dec 4, 2024 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Nongwoobio has 16.03 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 16.03M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.04% |
Owned by Institutions (%) | 0.66% |
Float | 6.74M |
Valuation Ratios
The trailing PE ratio is 11.15.
PE Ratio | 11.15 |
Forward PE | n/a |
PS Ratio | 0.80 |
PB Ratio | 0.43 |
P/TBV Ratio | 0.44 |
P/FCF Ratio | 10.47 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.56, with an EV/FCF ratio of 9.73.
EV / Earnings | 10.35 |
EV / Sales | 0.74 |
EV / EBITDA | 5.56 |
EV / EBIT | 8.05 |
EV / FCF | 9.73 |
Financial Position
The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.09.
Current Ratio | 4.25 |
Quick Ratio | 1.87 |
Debt / Equity | 0.09 |
Debt / EBITDA | 1.20 |
Debt / FCF | 2.10 |
Interest Coverage | 13.01 |
Financial Efficiency
Return on equity (ROE) is 4.02% and return on invested capital (ROIC) is 2.90%.
Return on Equity (ROE) | 4.02% |
Return on Assets (ROA) | 2.56% |
Return on Capital (ROIC) | 2.90% |
Revenue Per Employee | 412.43M |
Profits Per Employee | 29.67M |
Employee Count | 348 |
Asset Turnover | 0.44 |
Inventory Turnover | 0.67 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.07% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -12.07% |
50-Day Moving Average | 7,287.20 |
200-Day Moving Average | 7,697.50 |
Relative Strength Index (RSI) | 44.68 |
Average Volume (20 Days) | 16,274 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nongwoobio had revenue of KRW 143.53 billion and earned 10.33 billion in profits. Earnings per share was 644.16.
Revenue | 143.53B |
Gross Profit | 71.65B |
Operating Income | 13.28B |
Pretax Income | 12.34B |
Net Income | 10.33B |
EBITDA | 19.21B |
EBIT | 13.28B |
Earnings Per Share (EPS) | 644.16 |
Balance Sheet
The company has 32.04 billion in cash and 23.04 billion in debt, giving a net cash position of 9.01 billion or 561.86 per share.
Cash & Cash Equivalents | 32.04B |
Total Debt | 23.04B |
Net Cash | 9.01B |
Net Cash Per Share | 561.86 |
Equity (Book Value) | 267.11B |
Book Value Per Share | 16,611.16 |
Working Capital | 152.01B |
Cash Flow
In the last 12 months, operating cash flow was 19.47 billion and capital expenditures -8.48 billion, giving a free cash flow of 10.99 billion.
Operating Cash Flow | 19.47B |
Capital Expenditures | -8.48B |
Free Cash Flow | 10.99B |
FCF Per Share | 685.59 |
Margins
Gross margin is 49.92%, with operating and profit margins of 9.25% and 7.19%.
Gross Margin | 49.92% |
Operating Margin | 9.25% |
Pretax Margin | 8.60% |
Profit Margin | 7.19% |
EBITDA Margin | 13.39% |
EBIT Margin | 9.25% |
FCF Margin | 7.66% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 2.79%.
Dividend Per Share | 200.00 |
Dividend Yield | 2.79% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 31.05% |
Buyback Yield | n/a |
Shareholder Yield | 2.79% |
Earnings Yield | 8.97% |
FCF Yield | 9.55% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Nongwoobio has an Altman Z-Score of 3.16.
Altman Z-Score | 3.16 |
Piotroski F-Score | n/a |